Stocktoria
Cosmos Health Inc. COSM
Nasdaq · XNAS · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries · website · IPO 2010-05-19
Cosmos Health Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $65.3M | $54.4M | $53.4M | $50.3M | $56.2M |
| Gross profit | $7.9M | $4.3M | $4.3M | $6.0M | $8.3M |
| R&D expense | $519,363 | $533,293 | $164,859 | — | — |
| Operating income | -$16.7M | -$15.5M | -$21.8M | -$7.5M | -$4.5M |
| Interest expense | $1.9M | $1.0M | $866,476 | $2.3M | $2.8M |
| Income tax | $0 | $0 | $0 | -$775,051 | $114,010 |
| Net income | -$19.1M | -$16.2M | -$18.5M | -$13.8M | -$8.0M |
| EPS (diluted) | $-0.63 | $-1.17 | $-2.15 | $-33.16 | $-23.74 |
| Operating cash flow | -$8.4M | -$7.7M | -$15.6M | -$14.9M | -$7.1M |
| Free cash flow | -$8.5M | -$8.1M | -$16.9M | -$14.9M | -$7.7M |
| Cash & equivalents | $715,674 | $315,105 | — | $20.7M | $286,487 |
| Inventory | $5.8M | $4.4M | $4.8M | $3.5M | $3.1M |
| Total assets | $65.5M | $54.3M | $66.0M | $68.0M | $49.4M |
| Total liabilities | $47.1M | $29.8M | $30.0M | $28.4M | $45.0M |
| Shareholders' equity | $18.4M | $24.5M | $36.0M | $39.3M | $4.4M |
Source: SEC EDGAR filings · CIK 0001474167 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.